Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Cramer

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|August 2, 1996
Bioisosterism as a molecular diversity descriptor: steric fields of single "topomeric" conformersR D Cramer, R D Clark, D E Patterson, et al.
Progress in Clinical and Biological Research|January 1, 1989
Mechanism-based analysis of enzyme inhibitors of amide bond hydrolysisG R Marshall, D Mayer, C B Naylor, et al.
Journal of Medicinal Chemistry|August 2, 1996
Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptorsD E Patterson, R D Cramer, A M Ferguson, et al.
Journal of Medicinal Chemistry|June 1, 1979
Application of quantitative structure-activity relationships in the development of the antiallergic pyranenaminesR D Cramer, K M Snader, C R Willis, et al.
Journal of Medicinal Chemistry|October 3, 1999
Prospective identification of biologically active structures by topomer shape similarity searchingR D Cramer, M A Poss, M A Hermsmeier, et al.
Journal of Medicinal Chemistry|June 1, 1979
Pyranenamines: a new series of antiallergic compoundsK M Snader, L W Chakrin, R D Cramer, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Medicinal Chemistry|August 2, 1996
Bioisosterism as a molecular diversity descriptor: steric fields of single "topomeric" conformersR D Cramer, R D Clark, D E Patterson, et al.
Progress in Clinical and Biological Research|January 1, 1989
Mechanism-based analysis of enzyme inhibitors of amide bond hydrolysisG R Marshall, D Mayer, C B Naylor, et al.
Journal of Medicinal Chemistry|August 2, 1996
Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptorsD E Patterson, R D Cramer, A M Ferguson, et al.
Journal of Medicinal Chemistry|June 1, 1979
Application of quantitative structure-activity relationships in the development of the antiallergic pyranenaminesR D Cramer, K M Snader, C R Willis, et al.
Journal of Medicinal Chemistry|October 3, 1999
Prospective identification of biologically active structures by topomer shape similarity searchingR D Cramer, M A Poss, M A Hermsmeier, et al.
Journal of Medicinal Chemistry|June 1, 1979
Pyranenamines: a new series of antiallergic compoundsK M Snader, L W Chakrin, R D Cramer, et al.
Pageof 2